TY - JOUR
T1 - Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatized dogs
AU - Shi, Z. Q.
AU - Giacca, A.
AU - Yamatani, K.
AU - Fisher, S. J.
AU - Lickley, H. L.A.
AU - Vranic, M.
PY - 1993
Y1 - 1993
N2 - β-Adrenergic blockade suppressed lipolysis and normalized the exercise- induced increments in glucose uptake (Glc(U)) and metabolic clearance rate (MCR) in alloxan-diabetic dogs with residual insulin, but not in insulin- deprived depancreatized dogs even when combined with methylpalmoxirate (MP), which suppresses fatty acid oxidation. The effects of a minimal amount of insulin (as in the alloxan-diabetic dog), were studied in depancreatized, 24- h insulin-deprived dogs during rest and treadmill exercise (6 km/h, 10% slope) using a 1/4 basal insulin infusion (50 μU · kg-1 · min-1, insulin, n = 6) alone, or with MP (20 mg · kg-1 · day orally, 2.5 days, MP + insulin, n = 6). At rest, insulin decreased circulating fatty acids (31%) and Glc (13%) and increased Glc(U) and MCR (86 and 72%). Glc production was unaffected. MP plus insulin markedly suppressed hepatic fatty acid oxidation, decreased Glc (44%) and Glc production (50%), and markedly increased MCR (128%). The exercise-induced increments in MCR were markedly improved only by MP plus insulin but were still lower than in the propranolol-treated alloxan-diabetic dogs. Plasma Glc inversely correlated with the exercise-induced increase in MCR (r = -0.86). We conclude that 1) acute infusion of subbasal insulin improved Glc(U) in depancreatized dogs at rest but not during exercise; 2) inhibition of fatty acid oxidation combined with subbasal insulin improved the exercise-induced increase in MCR; and 3) the difference in Glc(U) and MCR between the MP plus insulin-treated depancreatized dogs and the β-blockade-treated alloxan-diabetic dogs suggests a difference between acute and chronic effects of insulin.
AB - β-Adrenergic blockade suppressed lipolysis and normalized the exercise- induced increments in glucose uptake (Glc(U)) and metabolic clearance rate (MCR) in alloxan-diabetic dogs with residual insulin, but not in insulin- deprived depancreatized dogs even when combined with methylpalmoxirate (MP), which suppresses fatty acid oxidation. The effects of a minimal amount of insulin (as in the alloxan-diabetic dog), were studied in depancreatized, 24- h insulin-deprived dogs during rest and treadmill exercise (6 km/h, 10% slope) using a 1/4 basal insulin infusion (50 μU · kg-1 · min-1, insulin, n = 6) alone, or with MP (20 mg · kg-1 · day orally, 2.5 days, MP + insulin, n = 6). At rest, insulin decreased circulating fatty acids (31%) and Glc (13%) and increased Glc(U) and MCR (86 and 72%). Glc production was unaffected. MP plus insulin markedly suppressed hepatic fatty acid oxidation, decreased Glc (44%) and Glc production (50%), and markedly increased MCR (128%). The exercise-induced increments in MCR were markedly improved only by MP plus insulin but were still lower than in the propranolol-treated alloxan-diabetic dogs. Plasma Glc inversely correlated with the exercise-induced increase in MCR (r = -0.86). We conclude that 1) acute infusion of subbasal insulin improved Glc(U) in depancreatized dogs at rest but not during exercise; 2) inhibition of fatty acid oxidation combined with subbasal insulin improved the exercise-induced increase in MCR; and 3) the difference in Glc(U) and MCR between the MP plus insulin-treated depancreatized dogs and the β-blockade-treated alloxan-diabetic dogs suggests a difference between acute and chronic effects of insulin.
KW - fatty acid-glucose cycle
KW - methylpalmoxirate
UR - http://www.scopus.com/inward/record.url?scp=0027530994&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027530994&partnerID=8YFLogxK
U2 - 10.1152/ajpendo.1993.264.3.e334
DO - 10.1152/ajpendo.1993.264.3.e334
M3 - Article
C2 - 8460681
AN - SCOPUS:0027530994
SN - 0002-9513
VL - 264
SP - E334-E341
JO - American Journal of Physiology - Endocrinology and Metabolism
JF - American Journal of Physiology - Endocrinology and Metabolism
IS - 3 27-3
ER -